- Home
- BFH vs BEAM Comparison
BFH vs BEAM Comparison
Compare BFH & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFH
- BEAM
- Stock Information
- Founded
- BFH 1996
- BEAM 2017
- Country
- BFH United States
- BEAM United States
- Employees
- BFH N/A
- BEAM N/A
- Industry
- BFH Business Services
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFH Consumer Discretionary
- BEAM Health Care
- Exchange
- BFH Nasdaq
- BEAM Nasdaq
- Market Cap
- BFH 2.3B
- BEAM 1.9B
- IPO Year
- BFH N/A
- BEAM 2020
- Fundamental
- Price
- BFH $50.04
- BEAM $23.15
- Analyst Decision
- BFH Hold
- BEAM Buy
- Analyst Count
- BFH 18
- BEAM 10
- Target Price
- BFH $48.53
- BEAM $47.00
- AVG Volume (30 Days)
- BFH 759.9K
- BEAM 846.3K
- Earning Date
- BFH 10-24-2024
- BEAM 11-06-2024
- Dividend Yield
- BFH 1.68%
- BEAM N/A
- EPS Growth
- BFH N/A
- BEAM N/A
- EPS
- BFH 9.68
- BEAM N/A
- Revenue
- BFH $2,579,000,000.00
- BEAM $352,567,000.00
- Revenue This Year
- BFH N/A
- BEAM N/A
- Revenue Next Year
- BFH $0.38
- BEAM $8.94
- P/E Ratio
- BFH $5.17
- BEAM N/A
- Revenue Growth
- BFH N/A
- BEAM 339.83
- 52 Week Low
- BFH $26.08
- BEAM $16.95
- 52 Week High
- BFH $59.66
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- BFH 49.03
- BEAM 42.26
- Support Level
- BFH $47.05
- BEAM $22.67
- Resistance Level
- BFH $53.28
- BEAM $27.42
- Average True Range (ATR)
- BFH 1.49
- BEAM 1.22
- MACD
- BFH 0.42
- BEAM 0.00
- Stochastic Oscillator
- BFH 58.57
- BEAM 13.65
About BFH Bread Financial Holdings Inc.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains minority interest in its recently spun-off LoyaltyOne division, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.